PEOPLE WITH TYPE I DIABETES: AGE 18 AND OLDER (ISLET CELL TRANSPLANTATION USING BELATACEPT)
Study Name: Prevention of Autoimmune Destruction and Rejection of human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes Mellitus
Study Sponsors: Juvenile Diabetes Research Foundation
Principal Investigators: Dr Peter Stock and Dr Andrew Posselt
Who can sign up for this study? Type I Diabetics over 18 years of age, weighing less than 80kgs (175 lbs), with good kidney function and no previous transplant of any kind. Other inclusion and exclusion criteria apply.